Keywords: -amgen, starts, clinical, testing, tnf-bp, amgen, started
-Amgen Starts Clinical Testing Of TNF-bp
Article | 22 April 1996
- Amgen has started clinical testing of its tumor necrosis factor binding protein (TNF-bp), a candidate treatment for rheumatoid arthritis. TNF-bp ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
